Skip to main content

Advertisement

SpringerLink
Log in

Atypical neuroimaging findings in patients with acquired hepatocerebral degeneration

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

Acquired hepatocerebral degeneration (AHD) is now widely recognized by physicians. Although hyperintensity in the bilateral globus pallidus in T1-weighted magnetic resonance images (MRIs) are characteristic neuroimaging findings, accumulating reports indicate that atypical neuroimaging findings are not rare. This study aimed to describe the spectrum of atypical neuroimaging findings and related factors in patients with AHD.

Methods

From February 2017 to January 2019, a retrospective study was conducted of 28 patients with AHD in the Shengjing Hospital of China Medical University. The neurological manifestations, clinical parameters, and biochemical and neuroimaging findings were analyzed.

Results

Among 28 patients, 14 patients were diagnosed with viral hepatitis-caused hepatocirrhosis, which was the most common cause of AHD. Resting tremor, cognitive impairment, and parkinsonian gait were the most common neurologic symptoms. Bilateral globus pallidus T1-weighted hyperintensity was detected in 26 patients (26/28, 92.9%). Ten patients (10/28, 35.7%) were determined to have an atypical neuroimaging finding. Binary logistic regression analysis indicated that age at onset of neurologic symptoms (odds ratio = 1.29, 95% confidence interval [CI] 1.03–1.61; p = 0.030) and Child–Pugh scores (odds ratio = 2.52, 95% CI, 1.01–6.31; p = 0.048) were independently associated with atypical neuroimaging findings in AHD.

Conclusion

The clinical manifestations of AHD are diverse; resting tremor, cognitive impairment, and parkinsonian gait were the most common. More than one third of patients had atypical neuroimaging findings. Age at onset of neurologic symptoms and Child–Pugh scores may be important predictors of atypical neuroimaging findings in patients with AHD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Maffeo E, Montuschi A, Stura G, Giordana MT (2014) Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci 35(4):523–530. https://doi.org/10.1007/s10072-013-1458-x

    Article  PubMed  Google Scholar 

  2. Shin H-W, Park HK (2017) Recent updates on acquired Hepatocerebral degeneration. Tremor Other Hyperkinet Mov (N Y) 7:463–463. https://doi.org/10.7916/d8tb1k44

    Article  Google Scholar 

  3. Fernandez-Rodriguez R, Contreras A, de Villoria JG, Grandas F (2010) Acquired hepatocerebral degeneration: clinical characteristics and MRI findings. Eur J Neurol 17(12):1463–1470. https://doi.org/10.1111/j.1468-1331.2010.03076.x

    Article  CAS  PubMed  Google Scholar 

  4. Kulisevsky J, Pujol J, Junque C, Deus J, Balanzo J, Capdevila A (1993) MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology 43(12):2570–2573. https://doi.org/10.1212/wnl.43.12.2570

    Article  CAS  PubMed  Google Scholar 

  5. Iwasa M, Mifuji-Moroka R, Kuroda M, Moroka H, Fujita N, Kobayashi Y, Adachi Y, Gabazza EC, Matsuda H, Takei Y (2012) Regional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRI. Metab Brain Dis 27(4):551–557. https://doi.org/10.1007/s11011-012-9314-x

    Article  PubMed  Google Scholar 

  6. Park SA, Heo K (2004) Prominent cerebellar symptoms with unusual magnetic resonance imaging findings in acquired hepatocerebral degeneration. Arch Neurol 61(9):1458–1460. https://doi.org/10.1001/archneur.61.9.1458

    Article  PubMed  Google Scholar 

  7. Meissner W, Tison F (2011) Acquired hepatocerebral degeneration. Handb Clin Neurol 100:193–197. https://doi.org/10.1016/b978-0-444-52014-2.00011-2

    Article  PubMed  Google Scholar 

  8. Christensen E (2004) Prognostic models including the Child-Pugh, MELD and Mayo risk scores - where are we and where should we go? J Hepatol 41(2):344–350. https://doi.org/10.1016/j.jhep.2004.06.005

    Article  PubMed  Google Scholar 

  9. Renjen PN, Khanna L, Rastogi R, Khan NI (2013) Acquired hepatocerebral degeneration. BMJ Case Rep 2013:bcr2013009387. https://doi.org/10.1136/bcr-2013-009387

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nagappa M, Sinha S, Saini JS, Kallolimath P, Singh N, Kumar A, Bindu PS, Taly AB (2016) Non-Wilsonian hepatolenticular degeneration: clinical and MRI observations in four families from south India. J Clin Neurosci 27:91–94. https://doi.org/10.1016/j.jocn.2015.06.035

    Article  PubMed  Google Scholar 

  11. Hisahara S, Matsushita T, Kitamura M, Mezawa S, Nonaka M, Imai T, Shimohama S (2014) Long-term clinical and radiological improvement of chronic acquired hepatocerebral degeneration after obliteration of portosystemic shunt: report of a case. J Neurol Sci 346(1–2):303–306. https://doi.org/10.1016/j.jns.2014.07.068

    Article  PubMed  Google Scholar 

  12. Rajoriya N, Brahmania M, Feld JJ (2018) Implications of manganese in chronic acquired hepatocerebral degeneration. Ann Hepatol 18(1):274–278. https://doi.org/10.5604/01.3001.0012.7938

    Article  Google Scholar 

  13. Rose CF, Verkhratsky A, Parpura V (2013) Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans 41:1518–1524. https://doi.org/10.1042/bst20130237

    Article  CAS  PubMed  Google Scholar 

  14. Stracciari A, Mattarozzi K, D'Alessandro R, Baldin E, Guarino M (2008) Cognitive functioning in chronic acquired hepatocerebral degeneration. Metab Brain Dis 23(2):155–160. https://doi.org/10.1007/s11011-008-9088-3

    Article  PubMed  Google Scholar 

  15. Butterworth RF (2016) Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited. Metab Brain Dis 31(6):1211–1215. https://doi.org/10.1007/s11011-015-9746-1

    Article  CAS  PubMed  Google Scholar 

  16. Melzer N, Grimm A, Meuth SG, Solymosi L, Stoll G (2010) A pure cerebellar syndrome with corresponding ponto-cerebellar atrophy in acquired hepatocerebral degeneration. J Neurol Sci 292(1–2):96–98. https://doi.org/10.1016/j.jns.2010.02.022

    Article  PubMed  Google Scholar 

  17. Victor M, Adams RD, Cole M (1965) The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine 44(5):345–396. https://doi.org/10.1097/00005792-196509000-00001

    Article  CAS  PubMed  Google Scholar 

  18. Ravina BM, Lange N, Marek K, Holloway R, Eidelberg D (2005) The role of radiotracer imaging in Parkinson disease - reply. Neurology 65(7):1144–1145. https://doi.org/10.1212/01.WNL.0000149403.14458.7F

    Article  Google Scholar 

  19. Kreis R, Ross BD, Farrow NA, Ackerman Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182(1):19–27. https://doi.org/10.1148/radiology.182.1.1345760

    Article  CAS  PubMed  Google Scholar 

  20. Erro R, Vitale C, Picillo M, Barone P, Pellecchia MT (2013) Early MRI findings in acquired hepatocerebral degeneration. Neurol Sci 34(4):589–591. https://doi.org/10.1007/s10072-012-1087-9

    Article  PubMed  Google Scholar 

  21. Cerase A, Rubenni E, Rufa A, Vallone I, Galluzzi P, Coratti G, Franchi F, Giannini F, Venturi C (2011) CT and MRI of Wernicke's encephalopathy. Radiol Med 116(2):319–333. https://doi.org/10.1007/s11547-011-0618-x

    Article  CAS  PubMed  Google Scholar 

  22. Muccio CF, De Lipsis L, Belmonte R, Cerase A (2019) Reversible MR findings in Marchiafava-Bignami disease. Case Rep Neurol Med 2019:1951030. https://doi.org/10.1155/2019/1951030

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People’s Republic of China

    Xiaoyu Dong & Jianfei Nao

Authors
  1. Xiaoyu Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jianfei Nao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jianfei Nao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, informed consent is not required.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, X., Nao, J. Atypical neuroimaging findings in patients with acquired hepatocerebral degeneration. Neurol Sci 41, 175–181 (2020). https://doi.org/10.1007/s10072-019-04068-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-04068-y

Keywords

Search

Navigation